318
Views
35
CrossRef citations to date
0
Altmetric
Original Research

Nano-ropinirole for the management of Parkinsonism: blood–brain pharmacokinetics and carrier localization

, , , , , & show all
 

Abstract

Aim: The aim of this study was to investigate the brain targeting potential of chitosan-coated oil in water nanoemulsions (CSNEROP) delivered intranasally in haloperidol-induced Parkinson's disease rat models. Methods: Chitosan-coated nanoemulsion (CSNEROP) was developed through aqueous titration followed by a high pressure homogenization method. Results: Gamma-scintigraphy study showed a significantly high mucoadhesive potential of CSNEROP and least for conventional and homogenized formulations. Confocal study showed deep localization of formulations in the brain confirming the permeation potential of CSNEROP. Pharmacokinetic results of CSNEROP in Wistar rat brain and plasma showed a significantly high (p** < 0.005) AUC0→24 and amplified Cmax over i.v treatment group. Neurobehavioral activity (rotarod and swim tests) and biochemical parameters (glutathion, TBARS and SOD) corroborated well with the pharmacokinetic results. The order of dopamine recovery in haloperidol-induced Wistar rats was found to be i.nCSNEROP group>i.nSolnROP group>i.vSolnROP group>haloperidol group. Conclusions: Finally, the investigation demonstrated that intranasal delivery of mucoadhesive nanocarrier might play as a potential candidate in the management of Parkinson's disease and related brain disorders.

Acknowledgements

The authors are thankful to Council for Scientific and Industrial Research (CSIR), New Delhi for CSIR-SRF which supported this study. The help provided by SAIF, AIIMS, New Delhi for using transmission electron microscopy facility for surface morphology cannot be left unacknowledged.

Financial & competing interests disclosure

Wockhardt Pharmaceuticals (Aurangabad, India), Gattefosse (Saint Priest, Cedex France) and Nikko Chemical Ltd (Japan) provided ROP, transcutol and sefsol 218, respectively. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Key issues
  • Mucoadhesive and thermodynamically stable nano-ropinirole was developed by aqueous titration technique.

  • The penetrating potential of nano-ropinirole was determined by confocal microscopy.

  • Surface coating of nano-ropinirole with cationic charged mucoadhesive carbohydrate was authenticated by scintigraphy.

  • A novel technique for simultaneous in vitro, ex vivo, and in vivo study.

  • UHPLC-MS/MS-Q-TOF-based pharmacokinetic study and brain targeting potential.

  • Formulation effectiveness interns of pharmacodynamic study were conducted in a haloperidol-induced rat model.

  • Study showed intranasal drug delivery system could be a promising route for brain targeting.

Notes

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.